Google
CALC — CALCIMEDICA, INC. COMMON STOCK (Healthcare >> Biotechnology)
CALC FAQ
What is CALC's P/E ratio?
CALCIMEDICA, INC. COMMON STOCK (CALC) currently trades at a P/E ratio of 2.70.
What is CALC's ROE?
CALCIMEDICA, INC. COMMON STOCK reports a Return on Equity (ROE) of 1,770.29%.
What is CALC's dividend yield?
CALCIMEDICA, INC. COMMON STOCK offers a dividend yield of 0.00%.
What is CALC's Deepscope Quality Score?
Deepscope rates CALC's overall financial quality at 46 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy CALC?
Deepscope's AI Timing Score for CALC is 51 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does CALC belong to?
CALCIMEDICA, INC. COMMON STOCK is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 1.06
Price
0.21
(24.62%)
Day Change
|
|
|---|
CALC, the overall quality is not good ( Quality = 46) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
Acceleration of ROE growth rate is below our criteria.
ROA is too relatively low compare to ROE
Growth of ROA was below our criteria in the last year.
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 98 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.06 |
| PBV / Sector |
-12.17 / 4.63
|
| Earning Per Share | -1.54 |
| PE / Sector |
2.70 / 17.43
GREAT
|
| PEG or PE/Growth / Sector |
-0.06 / 0.53
|
| Average 1M Daily Value |
0.26 M
GREAT
|
| Average 1W Daily Value |
0.71 M
GREAT
|
| Timing Factors |
|
100% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:28 |
| Symbol | CALC |
| Name | CALCIMEDICA, INC. COMMON STOCK |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 15.80 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 13.43 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 505 Coast Boulevard South, La Jolla, CA, United States, 92037
Phone: 858 952 5500
Website: https://calcimedica.com
Sector: Healthcare >> Biotechnology
Description: CalciMedica, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for illnesses caused by inflammatory and immunologic processes and direct cellular damage. Its lead product candidate comprises Auxora, an intravenous formulated small molecule calcium release-activated calcium (CRAC) channel inhibitors for the treatment of acute pancreatitis, asparaginase-induced pancreatic toxicity, and acute kidney injury, as well as severe COVID-19 pneumonia. The company also develops Auxora for the treatment of ulcerative colitis, traumatic brain injury, and allergic asthma; and oral CRAC channel inhibitors for use in chronic inflammatory and immunologic disease. The company is based in La Jolla, California.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
